World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
107
Citations
55057
World Ranking
1081
National Ranking
650

Robert T. Abraham publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Robert T. Abraham sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 274 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Robert T. Abraham D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Robert T. Abraham sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 107 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Robert T. Abraham is affiliated with Pfizer in the United States and has contributed extensively to the fields of biochemistry, genetics, molecular biology, and medicine. Their research primarily focuses on molecular biology, pulmonary and respiratory medicine, pathology and forensic medicine, biomedical engineering, and oncology.

The scientist's work covers several key topics, including:

  • Genetic factors in colorectal cancer
  • Advanced breast cancer therapies
  • Metabolism, diabetes, and cancer
  • DNA repair mechanisms
  • Nuclear structure and function
  • CAR-T cell therapy research
  • Nanowire synthesis and applications

Robert T. Abraham has co-authored multiple studies with frequent collaborators such as Aaron N. Snead, Jason C. Green, Christie L. Eissler, Steffen M. Bernard, and Eileen Tran.

The researcher has published in a variety of scientific journals, with several recurrent venues including:

  • Nature
  • Molecular Cancer Research
  • UNC Libraries
  • Nature Communications
  • Cell Cycle

Among the recent research papers contributed to by Abraham are:

  • Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase (2024, Nature)
  • Direct control of CAR T cells through small molecule-regulated antibodies (2021, Nature Communications)
  • Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells (2020, Cell Cycle)
  • Anti-tumor immunity influences cancer cell reliance upon ATG7 (2020, OncoImmunology)
  • Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue (2024, bioRxiv, Cold Spring Harbor Laboratory)

Robert T. Abraham's studies intersect fundamental molecular mechanisms with clinical applications, including the modulation of cancer growth pathways and immune system interactions. Their research spans various experimental approaches relevant to cancer biology, drug discovery, and cellular therapies.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Cell cycle checkpoint signaling through the ATM and ATR kinases

    Robert T. Abraham

  • The PI3K pathway in human disease

    David A. Fruman;Honyin Chiu;Benjamin D. Hopkins;Shubha Bagrodia

  • Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism

    Anne-Claude Gingras;Steven P. Gygi;Brian Raught;Roberto D. Polakiewicz

  • Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin

    Christine C. Hudson;Mei Liu;Gary G. Chiang;Diane M. Otterness

  • A role for ATR in the DNA damage-induced phosphorylation of p53

    Randal S. Tibbetts;Kathryn M. Brumbaugh;Josie M. Williams;Jann N. Sarkaria

  • Inhibition of ATM and ATR Kinase Activities by the Radiosensitizing Agent, Caffeine

    Jann N. Sarkaria;Ericka C. Busby;Randal S. Tibbetts;Pia Roos

  • Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin

    Gregory J. Brunn;Christine C. Hudson;Aleksandar Sekulić;Aleksandar Sekulić;Aleksandar Sekulić;Josie M. Williams

  • Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

    Candace J. Sabers;Mary M. Martin;Gregory J. Brunn;Josie M. Williams

  • A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells

    Aleksandar Sekulić;Christine C. Hudson;James L. Homme;Peng Yin

  • Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-kinase

    G Powis;R Bonjouklian;R Bonjouklian;M M Berggren;M M Berggren;A Gallegos;A Gallegos

  • Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

    G. J. Brunn;J. Williams;C. Sabers;G. Wiederrecht

  • Immunopharmacology of rapamycin.

    Robert T. Abraham;Gregory J. Wiederrecht

  • Jurkat T cells and development of the T-cell receptor signalling paradigm

    Robert T. Abraham;Arthur Weiss

  • Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

    Randal S. Tibbetts;David Cortez;Kathryn M. Brumbaugh;Ralph Scully

  • Inhibition of Phosphoinositide 3-Kinase Related Kinases by the Radiosensitizing Agent Wortmannin

    Jann N. Sarkaria;Randal S. Tibbetts;Ericka C. Busby;Amy P. Kennedy

  • Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase.

    Gary G. Chiang;Robert T. Abraham

  • PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways.

    Robert T. Abraham

  • Distinct requirements for Ras oncogenesis in human versus mouse cells

    Nesrin M. Hamad;Joel H. Elconin;Antoine E. Karnoub;Wenli Bai

  • Functional Analysis of Human Microtubule-based Motor Proteins, the Kinesins and Dyneins, in Mitosis/Cytokinesis Using RNA Interference

    Changjun Zhu;Jian Zhao;Marina Bibikova;Joel D. Leverson

Frequent Co-Authors

Paul J. Leibson
Paul J. Leibson Mayo Clinic
Larry M. Karnitz
Larry M. Karnitz Mayo Clinic
Weiguo Zhang
Weiguo Zhang Duke University
Tarek S. Mansour
Tarek S. Mansour Pfizer (United States)
Garth Powis
Garth Powis Sanford Burnham Prebys Medical Discovery Institute
David J. McKean
David J. McKean Mayo Clinic
Jann N. Sarkaria
Jann N. Sarkaria Mayo Clinic
Garth Powis
Garth Powis Discovery Institute
John C. Lawrence
John C. Lawrence University of Virginia
Lawrence E. Samelson
Lawrence E. Samelson National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Biology and Biochemistry opens doors to diverse healthcare and science-related careers. Many students choose to expand their education or change paths completely by pursuing online degrees and certificates in related fields. This flexibility is especially valuable for working professionals or those seeking accelerated options.

If you’re interested in mental health nursing, the 1 year pmhnp program online offers a quick route to becoming a Psychiatric Nurse Practitioner. For those already holding a master’s in nursing, the fastest post master's fnp certificate helps advance toward becoming a Family Nurse Practitioner in a matter of months.

Students drawn to nutrition and wellness might consider an accelerated nutrition degree online for a direct path into dietetics. Nurses looking to advance their qualifications often select the rn to bsn online programs, which offer both convenience and affordability.

Together, these options showcase how online study can support seamless transitions between biology-based degrees and high-demand healthcare roles in the USA.

Best Scientists Citing Robert T. Abraham

Trending Scientists

Recently Published Articles